AVANIR PHARMACEUTICALS (AVNR)

[DoubleK]

I'm not as confident in the future of this company
as I once was, these coordinated hits by shorts to take
down the stock have been flawless. From the weak launch
that surprised analysts,to the congressional inquiry,and
now the ANDA filing are having the desired effect in
making the short position stronger.

We all know Nuedexta works, there is a market but
the green horn: Keith K. has performed abysmally
since approval. What is the guy doing to counter
these unrelenting attacks that have cost shareholders
dearly.

also,if the script data on Monday is weak, we'll see
the $2's.